Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

5.20

+0.14 (2.77%)

At close: Feb 3, 2026, 4:00 PM EST

5.10

-0.10 (-1.90%)

After-hours: Feb 3, 2026, 8:00 PM EST

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	387	216	113	35	44	113
Market Cap Growth	80.97%	91.16%	221.19%	-19.99%	-61.12%	200.36%
Enterprise Value	216	-48	98	-19	-14	49
Last Close Price	5.20	3.19	4.02	2.47	3.09	7.98
PS Ratio	359.59	148.28	78.65	6.49	-	11.23
PB Ratio	1.60	0.74	1.50	0.64	0.72	1.68
P/TBV Ratio	2.01	0.90	147.82	0.64	0.72	1.68
EV/Sales Ratio	200.68	-	68.42	-	-	4.86
Debt / Equity Ratio	0.01	0.01	0.03	-	0.01	0.01
Asset Turnover	0.00	0.01	0.02	-	-	0.25
Inventory Turnover	-	-	-	-	-	6.07
Quick Ratio	8.46	12.53	0.67	14.47	25.38	36.58
Current Ratio	8.66	12.68	1.08	17.07	26.18	37.37
Return on Equity (ROE)	-37.26%	-42.82%	-57.70%	-	-9.79%	-9.26%
Return on Assets (ROA)	-17.24%	-19.02%	-32.81%	-	-5.95%	-5.43%
Return on Capital Employed (ROCE)	-34.50%	-20.70%	-49.80%	-16.00%	-10.30%	-5.00%
Earnings Yield	-27.37%	-36.77%	-41.23%	-30.64%	-16.57%	-3.00%
FCF Yield	-27.61%	-33.72%	-33.68%	-30.42%	-18.17%	-2.85%
Buyback Yield / Dilution	-35.71%	-140.72%	-88.38%	-0.06%	-36.73%	-53.61%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q